StemEdit Gene Editing
License-free CRISPR Platform
AI-designed tools for stem cell engineering, hypoimmune cell development and translational research
StemEdit Gene Editing Service
Clinical & Research Projects
Custom gene editing services for iPSCs and mammalian cells including knockouts, knock-ins, multiplex editing, and hypoimmune engineering.
Landing Pad
Technology
Part of StemEdit Service
Precise insertion of therapeutic genes into engineered cells. Reuse an established landing pad to efficiently add or exchange genes, saving time and reducing lab costs.
StemEdit
B2M & CIITA KO Lines
Research Use
Ready-to-use, hypoimmune iPSC and iMSC lines with B2M and CIITA knockouts. Ideal for allogeneic cell therapy research and off-the-shelf applications.
StemEdit
OC-1 Protein
Ready for Your Laboratory
AI-designed OpenCRISPR-1 (OC-1) protein delivers strong editing activity, SpCas9-like on-target performance, and reduced off-target effects.
.png)
On the REPROCELL blog
Latest in Gene Editing
Why PBMCs matter in gene and cell therapies
Explore the vital role of PBMCs in gene therapy and translational research, highlighting their importance in understanding immune responses and treatment efficacy.
23 July 2026
Empowering the Future of Gene Editing with StemEdit OC-1 Protein
Discover the innovative StemEdit OC-1 Protein, a generative AI-designed gene-editing enzyme that enhances genome engineering with improved safety and efficiency.
20 July 2026
.png?width=756&height=425&name=hubspot_featured_image_1200x628%20(1).png)
AI-Designed CRISPR Enables Hypoimmune iPSC Engineering for Off-the-Shelf Cell Therapy
REPROCELL's StemEdit platform enables the creation of hypoimmune iPSCs for scalable off-the-shelf cell therapies, reducing immune rejection and enhancing patient access.
04 June 2026